The white paper Pathways to Bioeconomy and Bioconvergence: Perspectives from Serbia and Israel offers a look at how two nations are shaping dynamic, innovation-driven bioeconomies through strategic investment and technological integration.
Serbia is harnessing its strengths in digital infrastructure, artificial intelligence and biotechnology, most notably through the development of the BIO4 Campus, a future hub for biotech in Eastern Europe. Meanwhile, Israel positions bioconvergence, an interdisciplinary blend of biology, engineering and computation, as a national strategic priority. Through detailed case studies, it explores how regulatory innovation, talent cultivation and market facilitation work together to translate scientific breakthroughs into tangible socioeconomic benefits.
Developed in collaboration with the World Economic Forum’s Centres for the Fourth Industrial Revolution in both countries, the white paper offers key insights into policy development, cross-sector collaboration and ecosystem building. It serves as a practical roadmap for stakeholders interested in harnessing science and technology to accelerate the global transition to a sustainable, bio-based economy.